Mellonie Boyd

Chronic administration of adenosine A3 receptor agonist and cerebral ischemia: neuronal and glial effects

Dag K.J.E. Von Lubitz, Rick C.S. Lin, Mellonie Boyd et al. · European Journal of Pharmacology · 1999 · 61 citations · Full text

Cerebral Ischemia, Neurophysiology, Chronic Administration +14

Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist

Dag K.J.E. Von Lubitz, Rick C.S. Lin, Norbert Bischofberger et al. · European Journal of Pharmacology · 1999 · 53 citations · Full text

Ischemic Damage, Adenosine Amine Congener, Functional Selectivity +6

Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils

Dag K.J.E. Von Lubitz, Rick C.S. Lin, Ian A. Paul et al. · European Journal of Pharmacology · 1996 · 49 citations

Adenosine Amine Congener, Medicine, Physiology +3

Properties of phagocyte NADPH oxidase p47-phox mutants with unmasked SH3 (Src homology 3) domains: full reconstitution of oxidase activity in a semi-recombinant cell-free system lacking arachidonic acid

Guihong Peng, Jin Huang, Mellonie Boyd et al. · Biochemical Journal · 2003 · 22 citations · Full text

Protein Function, Signal Transduction, Biochemistry +15